REG - Eden Research plc - First Mevalone authorisation for domestic use

Eden ResearchAnnouncement

30/01/2023 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230130:nRSd1645Oa&default-theme=true

RNS Number : 1645O  Eden Research plc  30 January 2023

 

30 January 2023

 

 

Eden Research Plc

("Eden" or "Company")

First Mevalone authorisation for domestic use

 

Eden Research plc (AIM: EDEN), the AIM-quoted company focused on sustainable
biopesticides and plastic-free formulation technology for use in the global
crop protection, animal health and consumer products industries, announces
that its flagship biofungicide, Mevalone(®), has received authorisation for
home garden use in Italy for the control of a number of important plant
pathogens affecting the home grower.  The diseases include Botrytis cinerea
and powdery mildew, destructive fungal pathogens affecting many plant species.

 

Mevalone, which is marketed as 3LOGY(®) in Italy, is already approved for
agricultural use across a wide range of crops including: wine and table
grapes, tomatoes, apple, pears, strawberries, cucumber, and many more.
Approval for 3LOGY has now been granted for domestic use across a number of
crops, allowing retailers to sell 3LOGY to gardeners in Italy for home
applications. The use of 3LOGY affords farmers and home growers maximum
flexibility in their plant and crop protection as it is free from residues and
provides them the important benefit of avoiding higher-than-permitted
pesticide residue levels as stipulated by the regulatory authorities.

 

3LOGY is distributed exclusively in Italy by Eden's distribution partner,
Sipcam-Oxon ("Sipcam"). Based on natural active ingredients, 3LOGY is a useful
tool in plant protection programmes and is aligned with the demanding
requirements of integrated pest management programmes. Sipcam has extensive
experience with 3LOGY and has also supported significant label extensions in
Spain and Portugal. This approval will enable Sipcam to expand the market for
3LOGY into homes across Italy.

 

For further information contact:

 

 Eden Research plc                                     www.edenresearch.com (http://www.edenresearch.com/)
 Sean Smith                                            01285 359 555

Alex Abrey

 Cenkos Securities plc (Nominated advisor and broker)
 Giles Balleny / Max Gould (corporate finance)         020 7397 8900

Michael Johnson (sales)

 Hawthorn Advisors (Financial PR)
 Felix Meston                                          eden@hawthornadvisors.com (mailto:eden@hawthornadvisors.com)

Simon Woods

 

 

Notes to Editors:

 

Eden Research is the only UK-listed company focused on biopesticides for
sustainable agriculture. It develops and supplies innovative biopesticide
products and natural microencapsulation technologies to the global crop
protection, animal health and consumer products industries.

 

Eden's products are formulated with terpene active ingredients, based on
natural plant defence metabolites. To date, they have been primarily used on
high-value fruits and vegetables, improving crop yields and marketability,
with equal or better performance when compared with conventional pesticides.
Eden has two products currently on the market:

 

Based on plant-derived active ingredients, Mevalone® is a foliar biofungicide
which initially targets a key disease affecting grapes and other high-value
fruit and vegetable crops.  It is a useful tool in crop defence programmes
and is aligned with the requirements of integrated pest management programmes.
It is approved for sale in a number of key countries whilst Eden and its
partners pursue regulatory clearance in new territories thereby growing Eden's
addressable market globally.

 

Cedroz™ is a bionematicide that targets free living nematodes which are
parasitic worms that affect a wide range of high-value fruit and vegetable
crops globally.  Cedroz is registered for sale on two continents and Eden's
commercial collaborator, Eastman Chemical, is pursuing registration and
commercialisation of this important new product in numerous countries
globally.

 

Eden's Sustaine® encapsulation technology is used to harness the biocidal
efficacy of naturally occurring chemicals produced by plants (terpenes) and
can also be used with both natural and synthetic compounds to enhance their
performance and ease-of-use. Sustaine microcapsules are naturally-derived,
plastic-free, biodegradable micro-spheres derived from yeast. It is one of the
only viable, proven and immediately registerable solutions to the
microplastics problem in formulations requiring encapsulation.

 

Eden was admitted to trading on AIM on 11 May 2012 and trades under the symbol
EDEN, as well as in the United States on OTC under the symbol EDNSF. It was
awarded the London Stock Exchange Green Economy Mark in January 2021, which
recognises London-listed companies that derive over 50% of their total annual
revenue from products and services that contribute to the global green
economy. Eden derives 100% of its total annual revenues from sustainable
products and services.

 

For more information about Eden, please visit:  www.edenresearch.com.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  REANKOBDOBKDFDB